Načítá se...
cs en

O CBD

 CBD

 About CBD

CBD – Kanabidiol (cannabidiol) je jeden ze dvou nejznámějších a co se týče účinků nejvýznamnějších kanabinoidů. Nachází se v rostlině Cannabis sp.. Oproti THC nemá CBD psychotropní účinky a existuje řada renomovaných studií o účincích CBD na lidský organismus.

CBD se připisuje výrazný protizánětlivý účinek, napomáhá zvyšovat obranyschopnost těla v boji s virovými i bakteriálními infekcemi, pomáhá při léčbě chronické bolesti, úzkosti, nespavosti a depresi. Lze též nalézt studie pozitivního vlivu CBD při léčbě Alzheimerovy a Parkinsonovy choroby, kde dokáže zlepšit kvalitu života pacientů. CBD může také napomoci proti propuknutí cukrovky II.typu a stejně tak může minimalizovat negativní dopady chemoterapie u onkologických pacientů. Dokonce existují studie na myších, kde byla prokázána inhibice růstu nádorových buněk.

  

CBD schéma

 

Reference:

CAMPOS, Alline Cristina, Fabricio Araújo MOREIRA, Felipe Villela GOMES, Elaine Aparecida DEL BEL a Francisco Silveira GUIMARÃES. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philosophical Transactions of the Royal Society B: Biological Sciences [online]. 2012, 367(1607), 3364–3378. ISSN 0962-8436.

 HAZEKAMP, Arno, Justin T. FISCHEDICK, Mónica Díez LLANO, Andrea LUBBE a Renee L. RUHAAK. Chemistry of Cannabis. Comprehensive Natural Products II: Chemistry and Biology [online]. 2010, 3, 1033–1084.

 TEATINI, Francesco, Luciano DEOTTO, Bruno BONETTI, Mara TURRI, Valeria TUGNOLI, Giovanna SQUINTANI, Francesco DONATO a Giampietro ZANETTE. Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials. Medicines [online]. 2018, 5(3), 59. ISSN 2305-6320.

MAROON, Joseph, Jeff BOST a Christina MATHYSSEK. Nutritional & medical applications for cannabidiol: Hemp health benefits without THC. In: Anti-Aging Therapeutics - 2014 Conference Year. 2014, s. 99–108. ISBN 9781934715185.

 IZZO, Angelo A., Francesca BORRELLI, Raffaele CAPASSO, Vincenzo DI MARZO a Raphael MECHOULAM. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences [online]. 2009, 30(10), 515–527. ISSN 01656147.

LINGE, Raquel, Laura JIMÉNEZ-SÁNCHEZ, Leticia CAMPA, Fuencisla PILAR-CUÉLLAR, Rebeca VIDAL, Angel PAZOS, Albert ADELL a Álvaro DÍAZ. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology [online]. 2016, 103(9), 16–26. ISSN 00283908.

PHILPOTT, Holly T., Melissa OʼBRIEN a Jason J. MCDOUGALL. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. PAIN [online]. 2017, 158(12), 2442–2451. ISSN 0304-3959.

BURSTEIN, Sumner. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry [online]. 2015, 23(7), 1377–1385. ISSN 09680896.

SHANNON, Scott a Janet OPILA-LEHMAN. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. The Permanente journal [online]. 2016, 20(4), 108–111. ISSN 15525775.

 ESPOSITO, Giuseppe, Daniele De FILIPPIS, Carla CIRILLO, Teresa IUVONE, Elena CAPOCCIA, Caterina SCUDERI, Antonio STEARDO, Rosario CUOMO a Luca STEARDO. Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview. Phytotherapy Research [online]. 2013, 27(5), 633–636. ISSN 0951418X.

 MORGAN, Celia J.A., Ravi K. DAS, Alyssa JOYE, H. Valerie CURRAN a Sunjeev K. KAMBOJ. Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings. Addictive Behaviors [online]. 2013, 38(9), 2433–2436. ISSN 03064603.

SHOELSON, Steven E, Jongsoon LEE, Allison B GOLDFINE, Steven E SHOELSON, Jongsoon LEE a Allison B GOLDFINE. Inflammation and insulin resistance. J Clin Invest [online]. 2006, 116(August), 1793–1801.

CHAGAS, Marcos Hortes N, Antonio W ZUARDI, Vitor TUMAS, Márcio Alexandre PENA-PEREIRA, Emmanuelle T SOBREIRA, Mateus M BERGAMASCHI, Antonio Carlos DOS SANTOS, Antonio Lucio TEIXEIRA, Jaime EC HALLAK a José Alexandre S CRIPPA. Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial. Journal of Psychopharmacology [online]. 2014, 28(11), 1088–1098. ISSN 0269-8811.

ROCK, E. M., D. BOLOGNINI, C. L. LIMEBEER, M. G. CASCIO, S. ANAVI-GOFFER, P. J. FLETCHER, R. MECHOULAM, R. G. PERTWEE a Linda A. PARKER. Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT 1A somatodendritic autoreceptors in the dorsal raphe nucleus. British Journal of Pharmacology [online]. 2012, 165(8), 2620–2634. ISSN 00071188.

FERRO, R., A. ADAMSKA, R. LATTANZIO, I. MAVROMMATI, C. E. EDLING, S. A. ARIFIN, C. A. FYFFE, G. SALA, L. SACCHETTO, G. CHIORINO, V. DE LAURENZI, M. PIANTELLI, O. J. SANSOM, T. MAFFUCCI a M. FALASCA. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene [online]. 2018, 37(49), 6368–6382. ISSN 0950-9232.

MASSI, Paola, Marta SOLINAS, Valentina CINQUINA a Daniela PAROLARO. Cannabidiol as potential anticancer drug. British Journal of Clinical Pharmacology [online]. 2013, 75(2), 303–312. ISSN 03065251.